Skip Navigation

Publication Detail

Title: The Jun N-terminal kinase inhibitor SP600125 is a ligand and antagonist of the aryl hydrocarbon receptor.

Authors: Joiakim, Aby; Mathieu, Patricia A; Palermo, Christine; Gasiewicz, Thomas A; Reiners Jr, John J

Published In Drug Metab Dispos, (2003 Nov)

Abstract: Exposure of the immortalized human breast epithelial cell line MCF10A to the Jun N-terminal kinase (JNK) inhibitor anthra[1,9-cd]pyrazol-6(2H)-one (SP600125) suppressed, in a concentration-dependent manner (IC50 is approximately 2 microM), the induction of CYP1A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Cotreatment with SP600125 also suppressed the accumulation of TCDD-induced nuclear aryl hydrocarbon receptor (AhR)-DNA complexes, as assessed by electrophoretic mobility shift assays. Concentrations of SP600125 < or = 50 microM did not transform the AhR into a DNA-binding species when added to rat liver cytosol. However, addition of SP600125 to cytosol just before TCDD addition completely suppressed AhR transformation and DNA binding (IC50 approximately 7 microM). Sucrose gradient analyses using rat liver and murine hepatoma 1c1c7 extracts demonstrated that SP600125 competed with TCDD for binding to the AhR. These results suggest that SP600125 is an AhR ligand and functions as an AhR antagonist at concentrations used to pharmacologically inhibit JNK.

PubMed ID: 14570754 Exiting the NIEHS site

MeSH Terms: Animals; Anthracenes/chemistry; Anthracenes/metabolism; Anthracenes/pharmacology*; Cell Line, Tumor; Cytochrome P-450 CYP1A1/antagonists & inhibitors; Cytochrome P-450 CYP1A1/metabolism; Enzyme Inhibitors/chemistry; Enzyme Inhibitors/metabolism; Enzyme Inhibitors/pharmacology*; JNK Mitogen-Activated Protein Kinases; Ligands; Liver/drug effects; Liver/enzymology; Mitogen-Activated Protein Kinases/antagonists & inhibitors*; Mitogen-Activated Protein Kinases/metabolism; Rats; Rats, Sprague-Dawley; Receptors, Aryl Hydrocarbon/antagonists & inhibitors*; Receptors, Aryl Hydrocarbon/metabolism

Back
to Top